Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I believe the company will emerge as a key player in the BCI space.
To the moon and back!
Today's volume is going to crash the system.
The level of interest in the BCI space is growing exponentially.
Looking at the EXPO 24 material, quality of speakers, and industry participation, I believe the company is setting up to be an important component in this field.
Outstanding management and technology. Share structure is tight.
I believe over 1,400 attended the 2024 Neuraseed Expo and the reviews were extremely positive.
If you want to see and hear the presentation from the Expo, here is the link. A lot of good information.
https://neuraseedbciexpo.vfairs.com/
My gut tells me NICO Corp may play a role in Neuraseed's journey.
Parallel Industries is Unparalleled.
EAPH is the best kept secret on the OTC Markets today. Shhhhhhh.
The company is in their "quiet" period.
Elon Musk's Neuralink Prepares For Second Human Trial, Aims 'Superpower' Capabilities
"Neuralink plans to implant its device into a second human patient in about a week, according to the company’s founder, Elon Musk. During a broadcast on the social media platform X (formerly Twitter), Musk shared that the company aims to have ‘high single digits’ of patients with the device by the end of the year. He and several Neuralink executives discussed the brain chip’s capabilities and future potential, such as treating paralysis and memory loss. They also addressed improvements for future surgeries to prevent issues encountered during the first implantation on Arizona man Noland Arbaugh. Musk emphasised that the long-term goal is to reduce the civilisational risk posed by AI by fostering “a closer symbiosis between human intelligence and digital intelligence.”
Elon Musk stated that the goal is “to give people superpowers,” as he announced that Neuralink will implement changes to address the issue of its electrode threads retracting from brain tissue in upcoming surgeries. To mitigate this problem, the proposed fixes include removing an air pocket that may have caused the threads to retract in the first surgery. Additionally, the company plans to insert the threads more accurately on the folds of the brain in future procedures, he explained.
Earlier in January, Neuralink successfully transplanted the device into the brain of a man who was paralysed from the shoulders down in a diving accident. After the implantation of Neuralink, the man was able to play chess, and video games and control the computer screen with his brain. Elon Musk has a strong passion for technology and constantly seeks to innovate in the field. Neuralink is a product of this mindset. The company, specialising in neural interface technology, is gaining attention for its unique chip. Neuralink has developed an AI-powered microchip capable of recording and interpreting brain activity. Remarkably, this chip is designed to help individuals overcome mental disabilities. The company asserts that the chip can even read your thoughts."
Elon Musk's Neuralink progress should positively affect others in the space such as Neuraseed under the leadership of Neilank K. Jha, MD, FRCS(C), MSc, MBA. CEO of Neuraseed.
Elon Musk's Neuralink Prepares For Second Human Trial, Aims 'Superpower' Capabilities: https://www.news18.com/business/elon-musks-neuralink-prepares-for-second-human-trial-aims-superpower-capabilities-8961904.html
An interesting behind-the-scenes look at Neuralink.
https://www.msn.com/en-us/health/other/ar-BB1pKYYa
Ah, I think you need to do a little more research and educate yourself.
It's quiet until one day--------------- it isn't.
This is a significant achievement and a solid step forward for the company. Good stuff.
The NeuraSeed BCI Expo 2024 is scheduled for August 2nd. The resulting outcome should provide significant positive exposure and position the company to share its plans with the investment community.
The conference attendees are leaders in the industry. Excellent exposure.
I believe they are setting themselves up for major success.
The fact Neuralink is considerably involved with this conference is significant. I'm impressed.
This baby is H.O.T.!!!!!!!!!!!!!!!
For someone with all the answers, it is......................well ....................simply amazing. 😂
No wonder you're confused. You may want to review it again for better comprehension.
Of course. Don't research. Don't do any investigation. Don't speak with ANYONE from the company.
Got it.😂
Call him and ask him as many questions to your hearts content.
You certainly have a lot of answers without asking anything.
Ah, these particular comments were made by Sava (Snakes employee).
It does appear The Wellington location is off to a great start.
Good reports are coming from The Wellington location.
It went up in smoke.
In hindsight, this was beneficial to the company in the long run.
He has a lot of idle time on his hands.
From all indications, Wellington seems to be doing well. Hope the trend continues.
We did it!
Yahoo.........
Big day today. A whopping 90 shares exchanged hands. Someone is in the know.
This baby is on F I R E!
The Phoenix is Rising.
Guess you'll have some sleepless nights waiting. LOL
Well, I guess you'll have to wait, sitting on the edge of your seat, to find out.
The Snakes and Lattes Virginia Beah location is in the process of remodeling to Snakes and Lattes standards. The location will be reopened on 3/16/24.
Additionally, some current and new staff are actively being trained conforming to Snakes and Lattes enterprise-wide protocols.
From Susan Lawver
Study Shows First-Ever Successful Deep-Brain Implant of Computer Chip in Living Animal
A first study demonstrating successful deep-brain placement of a brain computer interface microchip into a living animal with no apparent neurological effects is now published from Julian E. Bailes, MD, a recognized leader in the field of neurosurgery and co-director of the NorthShore University HealthSystem. Dr. Bailes' work has addressed the long-standing challenge of safely accessing subcortical regions of the brain for the purpose of microchip implantation without disrupting surrounding tissue.
"This study had two intentions," Dr. Bailes explained. "The first to describe the methodology for the successful implantation of an integrated circuit (IC) into the deep subcortical brain space, and secondly, to investigate how the mammalian brain would accept or reject the IC. We wanted to learn about potential damage to the neural architecture, whether infection would arise, and if the animal could survive with minimal or no functional change after subcortical placement of the IC."
First study of successful deep-brain implant of computer could lead to new treatments for many neurological disorders.
The proof-of-concept study was published in Brain-Computer Interfaces in September and used a modified and miniaturized NICO BrainPath, the world's first navigated trans-sulcal access technology widely used in Minimally Invasive Parafascicular Surgery (MIPS) for access in the removal of brain tumors and evacuation of hemorrhagic stroke.
The use of brain-computer interface (BCI) technologies is a rapidly developing area of interest in neurosurgery and medicine as a whole. BCI technologies thus far are placed at or just below the cortical surface; however, the majority of the brain's functional architecture is in the brain's interior. NICO technologies remove the barrier of deep-brain access by providing a safe pathway for delivery of a BCI into those subcortical regions, leading to possible treatments for many neurological disorders.
"It's such an exciting time in neurosurgery and the neurosciences," said Jim Pearson, president and CEO of NICO. "We are successfully leading the industry with our innovations that enable new opportunities not just for improved patient care and better outcomes, but also for merging the latest in minimally invasive technologies with the exploding area of artificial intelligence and a new generation of therapeutic and diagnostic technologies."
Pearson added that it's also an attractive emerging market for venture capitalist funding. According to a recent Wall Street Journal article, VCs are funding start-ups with medical device alternatives to medications for common but difficult to treat brain diseases. In the first half of this year, the article reports that U.S. and European neurological medical device makers garnered over $760 million in capital – the highest total among the 12 medical device markets analyzed and higher than the cardiovascular and orthopedic device markets.
NICO Corporation has led the MIS neurosurgical field for over a decade with its patented technologies that use the natural folds of the brain to reach and remove subcortical abnormalities. It is the sponsor of ENRICH, the world's first positive surgical trial for hemorrhagic stroke in which BrainPath and the NICO Myriad were used to achieve statistically significant and clinically meaningful improvements with early surgical intervention of spontaneous ICH versus medical management.
NICO advocates for and supports development of scientific evidence promoting safe and novel approaches to brain disorders and expanding clinical research efforts in pursuit of improved patient outcomes using MIPS. Its technologies have been featured in more than 180 peer-reviewed published papers with over 550 unique authors from major academic centers.
Learn about NICO technologies at NICOneuro.com; follow us on LinkedIn and Twitter, view surgical and patient videos on YouTube.
Merry Christmas Noghawbuck to you and your family.
Merry Christmas to all FUNN longs.
Thank you, Steve. Merry Christmas to you and your family. Hope you have a great holiday.